Prague Med. Rep. 2021, 122, 257-268

https://doi.org/10.14712/23362936.2021.23

Short Review of Liposteroid: A Novel Targeted Glucocorticoid Preparation for Treatment of Autoimmune and Inflammatory Diseases

Biplab K. Saha1, Nils T. Milman2

1Division of Pulmonary and Critical Care Medicine, Ozarks Medical Center, West Plains, USA
2Department of Clinical Biochemistry, Næstved Hospital, University College Zealand, Næstved, Denmark

Received March 16, 2021
Accepted October 20, 2021

References

1. Benameur, H., De Gand, G., Brasseur, R., Van Vooren, J. P., Legros, F. J. (1993) Liposome-incorporated dexamethasone palmitate: Chemical and physical properties. Int. J. Pharm. 89(3), 157–167. <https://doi.org/10.1016/0378-5173(93)90239-C>
2. Chen, X.-Y., Sun, J.-M., Huang, X.-J. (2017) Idiopathic pulmonary hemosiderosis in adults: Review of cases reported in the latest 15 years. Clin. Respir. J. 11(6), 677–681. <https://doi.org/10.1111/crj.12440>
3. Doi, T., Ohga, S., Ishimura, M., Takada, H., Ishii, K., Ihara, K., Nagai, H., Hara, T. (2013) Long-term liposteroid therapy for idiopathic pulmonary hemosiderosis. Eur. J. Pediatr. 172(11), 1475–1481. <https://doi.org/10.1007/s00431-013-2065-9>
4. Doi, T., Ohga, S., Ishimura, M., Takada, H., Ishii, K., Ihara, K., Nagai, H., Hara, T. (2015) Erratum to: Long-term liposteroid therapy for idiopathic pulmonary hemosiderosis. Eur. J. Pediatr. 174(12), 1701–1701. <https://doi.org/10.1007/s00431-015-2638-x>
5. Filipovich, A., McClain, K., Grom, A. (2010) Histiocytic disorders: Recent insights into pathophysiology and practical guidelines. Biol. Blood Marrow Transplant. 16, S82–S89 (Suppl. 1). <https://doi.org/10.1016/j.bbmt.2009.11.014>
6. Funauchi, M., Ohno, M., Yamagata, T., Nozaki, Y., Kinoshita, K., Kanamaru, A. (2003) Effects of liposteroid on the hemophagocytic syndrome in systemic lupus erythematosus. Lupus 12(6), 483–485. <https://doi.org/10.1191/0961203303lu373oa>
7. Furst, D. E., Saag, K. G. (2020) Determinants of glucocorticoid dosing. UpToDate.
8. Gregoriadis, G., Senior, J., Wolff, B., Kirby, C. (1984) Fate of liposomes in vivo: Control leading to targeting. In: Receptor-mediated Targeting of Drugs. Gregoriadis, G., Poste, G., Senior, J., Trouet, A., pp. 243–266, Plenum Press, New York.
9. Hoshi, K., Mizushima, Y., Shiokawa, Y., Kageyama, T., Honma, M., Kashiwazaki, S., Shichikawa, K., Tsunematsu, T., Kaneko, K. (1985) Double-blind study with liposteroid in rheumatoid arthritis. Drugs Exp. Clin. Res. 11(9), 621–626.
10. Ii, S., Okamoto, H., Yokoyama, K., Suyama, T. (1988) Comparative pharmacokinetic study of dexamethasone disodium phosphate in chronic rheumatoid arthritis patients. Yakuri to Chiryo 16, 865.
11. Kobayashi, Y., Salih, H. M., Kajiume, T., Nakamura, K., Miyagawa, S., Sato, T., Nishimura, S., Kobayashi, M. (2007) Successful treatment with liposteroid followed by reduced intensity stem cell transplantation in an infant with perforin deficiency presenting with hemophagocytic lymphohistiocytosis. J. Pediatr. Hematol. Oncol. 29(3), 178–182. <https://doi.org/10.1097/MPH.0b013e3180335030>
12. Kurosawa, Y., Morita, D., Shibazaki, T., Komori, K., Motobayashi, M., Shigemura, T., Tanaka, M., Nakazawa, Y. (2020) Dexamethasone palmitate is a feasible option for the treatment of chronic graft-vs-host disease, particularly with macrophage hyperactivation. Pediatr. Transplant. 24(1), e13627. <https://doi.org/10.1111/petr.13627>
13. Mizushima, Y., Hamano, T., Yokoyama, K. (1982) Tissue distribution and anti-inflammatory activity of corticosteroids incorporated in lipid emulsion. Ann. Paediatr. Rheumatol. 41(3), 263–267.
14. Mizushima, Y., Kaneko, K., Hoshi, K. (1983) Targeting steroid therapy in rheumatoid arthritis. Ann. Rheum. Dis. 42(4), 479–480. <https://doi.org/10.1136/ard.42.4.479>
15. Newton, R. (2000) Molecular mechanisms of glucocorticoid action: What is important? Thorax 55(7), 603–613. <https://doi.org/10.1136/thorax.55.7.603>
16. Nishiwaki, S., Terakura, S., Ito, M., Goto, T., Seto, A., Watanabe, K., Yanagisawa, M., Imahashi, N., Tsukamoto, S., Shimba, M., Ozawa, Y., Miyamura, K. (2009) Impact of macrophage infiltration of skin lesions on survival after allogeneic stem cell transplantation: A clue to refractory graft-versus-host disease. Blood 114(14), 3113–3116. <https://doi.org/10.1182/blood-2009-03-209635>
17. Nishiwaki, S., Nakayama, T., Murata, M., Nishida, T., Terakura, S., Saito, S., Kato, T., Mizuno, H., Imahashi, N., Seto, A., Ozawa, Y., Miyamura, K., Ito, M., Takeshita, K., Kato, H., Toyokuni, S., Nagao, K., Ueda, R., Naoe, T. (2014) Dexamethasone palmitate ameliorates macrophages-rich graft-versus-host disease by inhibiting macrophage functions. PLoS One 9(5), e96252. <https://doi.org/10.1371/journal.pone.0096252>
18. Oberfield, R. A., McCaffrey, J. A., Polio, J., Clouse, M. E., Lpn, T. H. (1979) Prolonged and continuous percutaneous intra-arterial hepatic infusion chemotherapy in advanced metastatic liver adenocarcinoma from colorectal primary. Cancer 44(2), 414–423. <https://doi.org/10.1002/1097-0142(197908)44:2<414::AID-CNCR2820440207>3.0.CO;2-3>
19. Ohga, S., Takahashi, K., Miyazaki, S., Kato, H., Ueda, K. (1995) Idiopathic pulmonary haemosiderosis in Japan: 39 possible cases from a survey questionnaire. Eur. J. Pediatr. 154(12), 994–995. <https://doi.org/10.1007/BF01958645>
20. RECOVERY Collaborative Group; Horby, P., Lim, W. S., Emberson, J. R., Mafham, M., Bell, J. L., Linsell, L., Staplin, N., Brightling, C., Ustianowski, A., Elmahi, E., Prudon, B., Green, C., Felton, T., Chadwick, D., Rege, K., Fegan, C., Chappell, L. C., Faust, S. N., Jaki, T., Jeffery, K., Montgomery, A., Rowan, K., Juszczak, E., Baillie, J. K., Haynes, R., Landray, M. J. (2021) Dexamethasone in hospitalized patients with Covid-19. N. Engl. J. Med. 384(8), 693–704.
21. Sadahiro, S., Suzuki, T., Tokunaga, N., Tajima, T., Makuuchi, H., Ohtaki, M. (2000) Prevention of hepatic artery occlusion during continuous infusion of fluorouracil using liposteroid. AJR Am. J. Roentgenol. 175(6), 1641–1642. <https://doi.org/10.2214/ajr.175.6.1751641>
22. Saha, B. K. (2020) Idiopathic pulmonary hemosiderosis: A state of the art review. Respir. Med. 176, 106234. <https://doi.org/10.1016/j.rmed.2020.106234>
23. Saha, B. K. (2021) Is it time to call idiopathic pulmonary hemosiderosis by the correct name: Immune-mediated pulmonary hemosiderosis? Am. J. Med. Sci. 361(6), 809–811. <https://doi.org/10.1016/j.amjms.2021.01.006>
24. Saha, B. K., Chong, W. H. (2021) Diffuse alveolar hemorrhage in cardiac diseases. Lung 199(2), 103–112. <https://doi.org/10.1007/s00408-021-00433-x>
25. Saha, B. K., Milman, N. T. (2021) Idiopathic pulmonary hemosiderosis: A review of the treatments used during the past 30 years and future directions. Clin. Rheumatol. 40(7), 2547–2557. <https://doi.org/10.1007/s10067-020-05507-4>
26. Saha, B. K., Bonnier, A., Chong, W. (2020) Antimalarials as antivirals for COVID-19: Believe it or not! Am. J. Med. Sci. 360(6), 618–630. <https://doi.org/10.1016/j.amjms.2020.08.019>
27. Sakamoto, R., Matsumoto, S., Mitsubuchi, H., Nakamura, K. (2018) Liposteroid and methylprednisolone combination therapy for a case of idiopathic lung hemosiderosis. Respir. Med. Case Rep. 24, 22–24.
28. Sakurai, Y., Ohkubo, Y., Miura, S., Mariko, M., Akazawa, H., Imanaka, Y., Kinoshita, S., Yoshioka, A. (1999) Liposteroid therapy for chronic childhood idiopathic thrombocytopenic purpura: Two case reports. Int. J. Pediatr. Hematol. Oncol. 6, 27–31.
29. Schiffelers, R. M., Banciu, M., Metselaar, J. M., Storm, G. (2006) Therapeutic application of long-circulating liposomal glucocorticoids in auto-immune diseases and cancer. J. Liposome Res. 16(3), 185–194. <https://doi.org/10.1080/08982100600851029>
30. Shefrin, A. E., Goldman, R. D. (2009) Use of dexamethasone and prednisone in acute asthma exacerbations in pediatric patients. Can. Fam. Physician 55(7), 704–706.
31. Shimizu, T. (1996) Treatment for gouty arthriti. Nihon Rinsho 54(12), 3267–3271. (in Japanese)
32. Suzuki, K., Takahashi, K., Matsuki, Y., Kawakami, M., Kawaguchi, Y., Hidaka, T., Sekiyama, Y., Mizukami, Y., Kawagoe, M., Nakamura, H. (1992) Fluorescent probe-labeled lipid microsphere uptake by human endothelial cells: A flow cytometric study. Jpn. J. Pharmacol. 60(4), 349–356. <https://doi.org/10.1254/jjp.60.349>
33. Tobai, H., Yano, J., Sato, N., Amanuma, F., Takahashi, M., Endo, M., Ishimura, M., Ohga, S., Maruyama, H. (2020) Successful liposteroid therapy for a recurrent idiopathic pulmonary hemosiderosis with Down syndrome. Case Rep. Pediatr. 2020, 1–5. <https://doi.org/10.1155/2020/5292947>
34. Tobler, A., Meier, R., Seitz, M., Dewald, B., Baggiolini, M., Fey, M. F. (1992) Glucocorticoids downregulate gene expression of GM-CSF, NAP-1/IL-8, and IL-6, but not of M-CSF in human fibroblasts. Blood 79(1), 45–51. <https://doi.org/10.1182/blood.V79.1.45.45>
35. Vishvakrama, P., Sharma, S. (2014) Liposomes: An overview. J. Drug Deliv. Ther. 4, 47–55.
36. Wakiguchi, H. (2017) Liposteroid therapy for juvenile and adult dermatomyositis: Efficacy and side effects. Ann. Transl. Med. 5(5), 110. <https://doi.org/10.21037/atm.2017.01.36>
37. Wakiguchi, H., Ohga, S. (2016) Clinical utility of the liposteroid therapy: Potential effects on the macrophage activation. Nihon Rinsho Meneki Gakkai Kaishi 39(3), 190–196. <https://doi.org/10.2177/jsci.39.190>
38. Wakiguchi, H., Hasegawa, S., Hirano, R., Kaneyasu, H., Wakabayashi-Takahara, M., Ohga, S. (2015) Successful control of juvenile dermatomyositis-associated macrophage activation syndrome and interstitial pneumonia: Distinct kinetics of interleukin-6 and -18 levels. Pediatr. Rheumatol. Online J. 13, 49. <https://doi.org/10.1186/s12969-015-0048-2>
39. Yamamoto, H., Asoh, M., Murakami, H., Kamiyama, N., Ohta, C. (1998) Liposteroid (dexamethasone palmitate) therapy for West syndrome: A comparative study with ACTH therapy. Pediatr. Neurol. 18(5), 415–419. <https://doi.org/10.1016/S0887-8994(98)00003-4>
40. Yamamoto, H., Fukuda, M., Miyamoto, Y., Murakami, H., Kamiyama, N. (2007) A new trial liposteroid (dexamethasone palmitate) therapy for intractable epileptic seizures in infancy. Brain Dev. 29(7), 421–424. <https://doi.org/10.1016/j.braindev.2006.12.002>
41. Yokoyama, K., Watanabe, M. (1996) Limethason as a lipid microsphere preparation: An overview. Adv. Drug Deliv. Rev. 20(2), 195–201. <https://doi.org/10.1016/0169-409X(95)00122-N>
42. Yokoyama, K., Okamoto, H., Watanabe, M., Suyama, T., Mizushima, Y. (1985) Development of a corticosteroid incorporated in lipid microspheres (liposteroid). Drugs Exp. Clin. Res. 11(9), 611–620.
43. Yoshikawa, H., Yamazaki, S., Abe, T., Oda, Y. (2000) Liposteroid therapy for refractory seizures in children. J. Child Neurol. 15(10), 702–704. <https://doi.org/10.1177/088307380001501014>
front cover

ISSN 1214-6994 (Print) ISSN 2336-2936 (Online)

Archive